EXICURE INC (XCUR) Stock Price & Overview
NASDAQ:XCUR • US30205M3097
Current stock price
The current stock price of XCUR is 3.777 USD. Today XCUR is down by -7.88%. In the past month the price decreased by -4.14%. In the past year, price decreased by -67.38%.
XCUR Key Statistics
- Market Cap
- 24.059M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.77
- Dividend Yield
- N/A
XCUR Stock Performance
XCUR Stock Chart
XCUR Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to XCUR. When comparing the yearly performance of all stocks, XCUR is a bad performer in the overall market: 95.06% of all stocks are doing better.
XCUR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to XCUR. While XCUR seems to be doing ok healthwise, there are quite some concerns on its profitability.
XCUR Earnings
XCUR Forecast & Estimates
XCUR Groups
Sector & Classification
XCUR Financial Highlights
Over the last trailing twelve months XCUR reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS increased by 81.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.23% | ||
| ROE | -125.98% | ||
| Debt/Equity | 0 |
XCUR Ownership
XCUR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.02 | 367.796B | ||
| AMGN | AMGEN INC | 15.37 | 189.224B | ||
| GILD | GILEAD SCIENCES INC | 15.72 | 172.517B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.4 | 110.97B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.97 | 79.171B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 47.19 | 42.718B | ||
| INSM | INSMED INC | N/A | 33.416B | ||
| NTRA | NATERA INC | N/A | 27.358B | ||
| BIIB | BIOGEN INC | 10.73 | 25.385B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.56 | 25.059B | ||
| MRNA | MODERNA INC | N/A | 20.21B | ||
| INCY | INCYTE CORP | 12.41 | 19.119B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.11B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About XCUR
Company Profile
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 7 full-time employees. The company went IPO on 2018-05-09. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The firm is also exploring strategic alternatives to maximize stockholder value.
Company Info
IPO: 2018-05-09
EXICURE INC
2430 N. Halsted St.
Chicago ILLINOIS 60614 US
CEO: David A. Giljohann
Employees: 7
Phone: 13026365400
EXICURE INC / XCUR FAQ
Can you describe the business of EXICURE INC?
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 7 full-time employees. The company went IPO on 2018-05-09. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The firm is also exploring strategic alternatives to maximize stockholder value.
What is the current price of XCUR stock?
The current stock price of XCUR is 3.777 USD. The price decreased by -7.88% in the last trading session.
Does XCUR stock pay dividends?
XCUR does not pay a dividend.
What is the ChartMill rating of EXICURE INC stock?
XCUR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for EXICURE INC?
EXICURE INC (XCUR) currently has 7 employees.
Can you provide the market cap for EXICURE INC?
EXICURE INC (XCUR) has a market capitalization of 24.06M USD. This makes XCUR a Nano Cap stock.